{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T22:59:30Z","timestamp":1777417170274,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jphs.2020.08.003","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T22:31:49Z","timestamp":1597789909000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model"],"prefix":"10.1016","volume":"144","author":[{"given":"Satoshi","family":"Kawakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Hagiwara-Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megumi","family":"Aimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Takahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2020.08.003_bib1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","article-title":"Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis","volume":"20","author":"Mei","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jphs.2020.08.003_bib2","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1016\/S0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jphs.2020.08.003_bib3","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1001\/jama.1990.03450210088038","article-title":"Torsades de pointes occurring in association with terfenadine use","volume":"264","author":"Monahan","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.jphs.2020.08.003_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/hrt.70.5.469","article-title":"Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion","volume":"70","author":"Broadhurst","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.jphs.2020.08.003_bib5","doi-asserted-by":"crossref","first-page":"6917","DOI":"10.1021\/jm060500o","article-title":"Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers","volume":"49","author":"Aronov","year":"2006","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.jphs.2020.08.003_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.yjmcc.2005.09.017","article-title":"Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel","volume":"40","author":"Ridley","year":"2006","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jphs.2020.08.003_bib7","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1540-8167.1999.tb00264.x","article-title":"Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole","volume":"10","author":"Zhou","year":"1999","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jphs.2020.08.003_bib8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1476-5381.2012.01880.x","article-title":"Does terfenadine-induced ventricular tachycardia\/fibrillation directly relate to its QT prolongation and Torsades de Pointes?","volume":"166","author":"Lu","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2020.08.003_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jphs.2016.05.001","article-title":"In\u00a0vivo analysis of torsadogenic potential of an antipsychotic drug paliperidone using the acute atrioventricular block rabbit as a proarrhythmia model","volume":"132","author":"Hagiwara","year":"2016","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2020.08.003_bib10","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/bph.13870","article-title":"The anaesthetized rabbit with acute atrioventricular block provides a new model for detecting drug-induced Torsade de Pointes","volume":"174","author":"Hagiwara","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2020.08.003_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.CIR.98.11.1125","article-title":"Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling","volume":"98","author":"Vos","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2020.08.003_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1254\/jjp.88.341","article-title":"Electrophysiological, anatomical and histological remodeling of the heart to AV block enhances susceptibility to arrhythmogenic effects of QT-prolonging drugs","volume":"88","author":"Sugiyama","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.jphs.2020.08.003_bib13","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.hrthm.2012.05.016","article-title":"Beat-to-beat variability of repolarization as a new biomarker for proarrhythmia in\u00a0vivo","volume":"9","author":"Varkevisser","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jphs.2020.08.003_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.hrthm.2017.11.011","article-title":"Beat-to-beat variations in activation-recovery interval derived from the right ventricular electrogram can monitor arrhythmic risk under anesthetic and awake conditions in the canine chronic atrioventricular block model","volume":"15","author":"Wijers","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jphs.2020.08.003_bib15","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1476-5381.2009.00407.x","article-title":"Long-term blockade of L\/N-type Ca2+ channels by cilnidipine ameliorates repolarization abnormality of the canine hypertrophied heart","volume":"158","author":"Takahara","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2020.08.003_bib16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0167-5273(83)90141-9","article-title":"Warning arrhythmias in ischemic heart disease","volume":"4","author":"Adgey","year":"1983","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jphs.2020.08.003_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2885.2003.00460.x","article-title":"Pharmacokinetics and pharmacodynamics of clemastine in healthy horses","volume":"26","author":"T\u00f6rneke","year":"2003","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.jphs.2020.08.003_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-3164.2004.00367.x","article-title":"Clinical pharmacology of clemastine in healthy dogs","volume":"15","author":"Hansson","year":"2004","journal-title":"Vet Dermatol"},{"key":"10.1016\/j.jphs.2020.08.003_bib19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/j.1552-4604.1996.tb04758.x","article-title":"The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations","volume":"36","author":"Schran","year":"1996","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jphs.2020.08.003_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1211\/0022357991772097","article-title":"Identification of urinary metabolites of clemastine after oral administration to man","volume":"51","author":"Choi","year":"1999","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.jphs.2020.08.003_bib21","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/rcm.1622","article-title":"Identification of some new clemastine metabolites in dog, horse, and human urine with liquid chromatography\/tandem mass spectrometry","volume":"18","author":"Tevell","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.jphs.2020.08.003_bib22","first-page":"59","article-title":"Effects of histamine H1 receptor antagonists on action potentials in Guinea-pig isolated papillary muscles","volume":"331","author":"Kii","year":"1996","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.jphs.2020.08.003_bib23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005344-199807000-00019","article-title":"\u201cConventional\u201d antihistamines slow cardiac repolarization in isolated perfused (Langendorff) feline hearts","volume":"32","author":"Wang","year":"1998","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2020.08.003_bib24","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/sj.bjp.0706493","article-title":"Long-term bradycardia caused by atrioventricular block can remodel the canine heart to detect the histamine H1 blocker terfenadine-induced torsades de pointes arrhythmias","volume":"147","author":"Takahara","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2020.08.003_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jphs.2016.04.024","article-title":"Possibility as an anti-cancer drug of astemizole: evaluation of arrhythmogenicity by the chronic atrioventricular block canine model","volume":"131","author":"Izumi-Nakaseko","year":"2016","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.jphs.2020.08.003_bib26","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1161\/01.CIR.103.23.2851","article-title":"Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall","volume":"103","author":"Yan","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2020.08.003_bib27","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/bjp.2008.240","article-title":"Sensitive and reliable proarrhythmia in\u00a0vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts","volume":"154","author":"Sugiyama","year":"2008","journal-title":"Br J Pharmacol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861320300839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861320300839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:00:15Z","timestamp":1761163215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861320300839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S1347861320300839"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2020.08.003","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Torsadogenic potential of a novel remyelinating drug clemastine for multiple sclerosis assessed in the rabbit proarrhythmia model","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2020.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}